Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

IQV

IQVIA Holdings Inc

Dec 12 • 04:00PM ET

200.37

Dollar change -0.70
Percentage change -0.35	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: CROX MEDP LH ICON CTLT CRL INCY

| Held by: VTI VOO VO SPY IVV VTV XLV VOT IBB VHT

Scroll to Statements

Index	S&P 500	P/E	26.28	EPS (ttm)	7.62	Insider Own	0.83%	Shs Outstand	181.60M	Perf Week	0.22%
Market Cap	36.37B	Forward P/E	16.70	EPS next Y	12.00	Insider Trans	-0.09%	Shs Float	180.00M	Perf Month	-6.18%
Income	1.41B	PEG	2.54	EPS next Q	3.11	Inst Own	92.93%	Short Float	1.73%	Perf Quarter	-16.06%
Sales	15.31B	P/S	2.37	EPS this Y	9.01%	Inst Trans	2.70%	Short Ratio	2.07	Perf Half Y	-6.35%
Book/sh	38.36	P/B	5.22	EPS next Y	7.91%	ROA	5.29%	Short Interest	3.11M	Perf Year	-7.85%
Cash/sh	9.43	P/C	21.24	EPS next 5Y	10.34%	ROE	22.00%	52W Range	187.62 - 261.73	Perf YTD	-13.40%
Dividend Est.	-	P/FCF	18.55	EPS past 5Y	42.42%	ROI	7.22%	52W High	-23.44%	Beta	1.49
Dividend TTM	-	Quick Ratio	0.81	Sales past 5Y	7.76%	Gross Margin	27.81%	52W Low	6.80%	ATR (14)	5.81
Dividend Ex-Date	-	Current Ratio	0.81	EPS Y/Y TTM	27.69%	Oper. Margin	14.13%	RSI (14)	42.86	Volatility	2.82% 3.05%
Employees	87000	Debt/Eq	1.97	Sales Y/Y TTM	3.17%	Profit Margin	9.17%	Recom	1.44	Target Price	248.62
Option/Short	Yes / Yes	LT Debt/Eq	1.79	EPS Q/Q	-5.28%	Payout	0.00%	Rel Volume	0.77	Prev Close	201.07
Sales Surprise	0.79%	EPS Surprise	0.56%	Sales Q/Q	4.06%	Earnings	Oct 31 BMO	Avg Volume	1.50M	Price	200.37
SMA20	0.22%	SMA50	-6.09%	SMA200	-12.64%	Trades		Volume	1,156,247	Change	-0.35%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-04-24	Initiated	RBC Capital Mkts	Outperform	$275
Jul-24-24	Downgrade	Jefferies	Buy → Hold	$266 → $242
Jun-06-24	Initiated	Goldman	Buy	$270
Feb-26-24	Initiated	Leerink Partners	Outperform	$290
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Feb-13-24	Initiated	BTIG Research	Buy	$285
Nov-02-23	Downgrade	Robert W. Baird	Outperform → Neutral	$248 → $202
Sep-06-23	Initiated	HSBC Securities	Buy	$260
Mar-17-23	Initiated	Truist	Buy	$265
Dec-06-22	Initiated	Cowen	Outperform	$251
Nov-17-22	Downgrade	Citigroup	Buy → Neutral	$275 → $245
Aug-25-22	Initiated	Credit Suisse	Outperform	$300
Jul-15-22	Initiated	SVB Leerink	Outperform	$256
May-24-22	Initiated	Guggenheim	Buy	$244
Apr-29-22	Upgrade	Piper Sandler	Neutral → Overweight	$231 → $255
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$235
Aug-05-21	Resumed	Credit Suisse	Outperform	$272
Apr-16-21	Upgrade	Stephens	Equal-Weight → Overweight	$180 → $250
Mar-08-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$218

Show Previous Ratings

Dec-04-24 10:55AM	A 12-Year-Olds Journey Into the World of Ozempic (The Wall Street Journal)
Dec-03-24 12:41AM	Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China (The Wall Street Journal)
Nov-06-24 04:15PM	IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024 (Business Wire)
Nov-05-24 07:11AM	Iqvia price target lowered to $265 from $280 at Morgan Stanley (TipRanks)
Nov-04-24 09:15AM	Interpreting IQVIA (IQV) International Revenue Trends (Zacks)
02:27PM	Loading…
Nov-01-24 02:27PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
03:10AM	IQVIA Holdings Inc (IQV) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges (GuruFocus.com)
01:04AM	Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight (GuruFocus.com)
12:45AM	Q3 2024 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Oct-31-24 08:30PM	IQVIA (IQV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:15AM	IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:13AM	IQVIA: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day (Business Wire)
Oct-30-24 09:42AM	IQVIA Holdings Inc. (IQV): Among UBS Top Tech Based Disruptive Stocks For 2030 (Insider Monkey)
Oct-28-24 09:16AM	Seeking Clues to IQVIA (IQV) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
10:01AM	Loading…
Oct-24-24 10:01AM	IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) -7.27%
Oct-15-24 04:15PM	IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 (Business Wire)
Oct-04-24 09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
Oct-02-24 09:00AM	IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI (Business Wire)
Sep-25-24 06:20PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
08:26AM	IQVIA Holdings Inc. (IQV): Hedge Funds Are Bullish On This Trending AI Stock Right Now (Insider Monkey)
Sep-19-24 09:00AM	IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award (Business Wire)
Sep-17-24 09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)
01:12AM	IQVIA Holdings Inc. (NYSE:IQV): A Non-Tech Stock With Long-Term Investment Potential (Insider Monkey)
Sep-13-24 01:41PM	Goldman Thinks IQVIA Holdings Inc. (IQV) Is A Long-Term AI Stock Set To Rally Eventually (Insider Monkey)
Sep-12-24 09:50AM	Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term (Zacks)
Sep-04-24 02:23PM	Contract Research Giant IQVIA's Data Assets Are Biggest Differentiator, Provides Best Exposure To AI And Data Opportunities: Analyst (Benzinga)
09:00AM	Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative (PR Newswire)
Aug-29-24 06:24PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Aug-21-24 04:15PM	IQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024 (Business Wire)
11:30AM	Loading…
11:30AM	IQVIA (IQV) Up 3.4% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-16-24 10:09AM	Here's Why You Should Retain IQVIA (IQV) Stock for Now (Zacks)
Aug-14-24 09:45AM	How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates (GlobeNewswire)
Jul-31-24 04:13PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Jul-29-24 09:15AM	Understanding IQVIA (IQV) Reliance on International Revenue (Zacks)
Jul-25-24 06:18PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Jul-24-24 03:26AM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Jul-23-24 09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
01:49AM	Q2 2024 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
01:00AM	Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight (GuruFocus.com)
Jul-22-24 06:30PM	Compared to Estimates, IQVIA (IQV) Q2 Earnings: A Look at Key Metrics (Zacks) +9.20%
04:28PM	Iqvia Bolts Higher After A Surprise Segment Beat Saved Its Second Quarter (Investor's Business Daily)
01:47PM	IQVIA Stock Pops After It Beats Q2 Earnings Estimates (Investopedia)
11:25AM	IQVIA (IQV) Surpasses Earnings & Revenue Estimates in Q2 (Zacks)
10:37AM	IQVIA 'Is A Solid Investment' With Strong Competitive Positioning, Analyst Says After Better Than Expected Q2 Earnings (Benzinga)
08:15AM	IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates (Zacks)
07:11AM	IQVIA: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Second-Quarter 2024 Results (Business Wire)
Jul-17-24 11:00AM	IQVIA (IQV) to Report Q2 Earnings: What's in the Offing? (Zacks)
Jul-16-24 06:28PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Jul-12-24 06:02AM	Will IQVIA Holdings (IQV) Bounce Back? (Insider Monkey)
Jul-11-24 08:30AM	IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group (Business Wire)
Jul-08-24 04:15PM	IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024 (Business Wire)
Jul-01-24 08:01AM	Clinical Development Expertise Aids IQVIA (IQV), Costs High (Zacks)
Jun-25-24 08:00AM	IQVIAs SmartSolve eQMS Wins 2024 MedTech Breakthrough Award Best Use of Artificial Intelligence in Healthcare (Business Wire)
Jun-18-24 08:49AM	The CRO Sector Looks Appealing, Says Goldman Sachs Here Are 2 Stocks to Consider (TipRanks)
06:13AM	Ranking the top ten clinical research organisations in the world (Pharmaceutical Technology)
Jun-13-24 12:23PM	IQVIA (IQV) Announces Launch of Trial Technology Platform (Zacks)
04:32AM	IQVIA introduces new trial technology platform for research sites (Clinical Trials Arena)
Jun-12-24 08:00AM	IQVIA Launches One Home Clinical Trial Technology Platform Solves Challenges and Reduces Overload at Sites (Business Wire)
Jun-10-24 08:00AM	IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses (Business Wire)
Jun-06-24 03:07PM	Final Trades: Amazon, Goldman Sachs, AbbVie and IQVIA Holdings (CNBC TV)
Jun-03-24 06:28PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
May-28-24 06:04AM	Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows (Reuters)
May-24-24 11:17AM	Here's Why You Should Hold on to IQVIA (IQV) Stock for Now (Zacks)
May-14-24 08:00AM	U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute (Business Wire)
May-09-24 04:15PM	IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024 (Business Wire)
May-07-24 06:49AM	Stifel Adjusts Price Target on IQVIA Holdings to $288 From $294 (MT Newswires)
May-04-24 09:27AM	IQVIA Holdings Inc. (NYSE:IQV) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-03-24 12:11PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
11:49AM	UBS Adjusts Price Target on IQVIA Holdings to $295 From $300, Maintains Buy Rating (MT Newswires)
11:17AM	Deutsche Bank Adjusts Price Target on IQVIA Holdings to $275 From $280 (MT Newswires)
11:00AM	Jefferies Adjusts Price Target on IQVIA to $266 From $281 (MT Newswires)
10:07AM	Morgan Stanley Adjusts Price Target on IQVIA to $270 From $275 (MT Newswires)
09:43AM	Truist Adjusts IQVIA Holdings' Price Target to $292 From $297, Keeps Buy Rating (MT Newswires)
09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
09:31AM	Baird Adjusts Price Target on IQVIA to $245 From $254 (MT Newswires)
08:11AM	Leerink Partners Adjusts Price Target on IQVIA to $278 From $290 (MT Newswires)
07:09AM	Evercore ISI Adjusts Price Target on IQVIA to $250 From $275 (MT Newswires)
03:32AM	IQVIA Holdings Inc (IQV) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
01:05AM	Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight (GuruFocus.com)
12:13AM	Q1 2024 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
May-02-24 11:55AM	IQV Stock Earnings: IQVIA Hldgs Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
11:47AM	IQVIA (IQV) Surpasses Earnings & Revenue Estimates in Q1 (Zacks)
10:12AM	IQVIA Holdings Inc (IQV) First Quarter 2024 Earnings: Surpasses Revenue Estimates (GuruFocus.com)
08:10AM	IQVIA Holdings (IQV) Tops Q1 Earnings and Revenue Estimates (Zacks)
08:04AM	IQVIA Holdings Q1 Adjusted Earnings, Revenue Increase (MT Newswires)
07:11AM	IQVIA: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports First-Quarter 2024 Results (Business Wire)
May-01-24 04:30PM	Analysts Are Pounding the Table on These 3 Stocks: April 2024 (InvestorPlace)
Apr-29-24 10:26AM	IQVIA (IQV) to Report Q1 Earnings: What's in the Offing? (Zacks)
09:16AM	Countdown to IQVIA (IQV) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-25-24 11:34AM	20 Fastest Growing Health Tech Companies in the World (Insider Monkey)
10:02AM	IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-24-24 12:34PM	10 Stocks Hedge Funds Are Talking About (Insider Monkey)
Apr-23-24 09:00AM	IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards (Business Wire)
Apr-18-24 05:00PM	19 Best Alternatives to Discord in 2024 (Insider Monkey)
Apr-17-24 12:00PM	Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now (Zacks)
Apr-15-24 04:15PM	IQVIA to Announce First-Quarter 2024 Results on May 2, 2024 (Business Wire)
Apr-08-24 04:01PM	IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud (Business Wire)

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sherbet Eric	See Remarks	Aug 27 '24	Sale	246.33	1,300	320,229	19,536	Aug 29 05:02 PM
Sherbet Eric	Officer	Aug 27 '24	Proposed Sale	246.33	1,300	320,229		Aug 27 05:23 PM
BOUSBIB ARI	See Remarks	Mar 01 '24	Option Exercise	65.16	42,847	2,791,911	828,430	Mar 04 05:28 PM
BOUSBIB ARI	See Remarks	Mar 01 '24	Sale	250.53	31,678	7,936,193	796,752	Mar 04 05:28 PM
STAUB W RICHARD	See Remarks	Feb 29 '24	Sale	247.80	14,100	3,494,034	15,945	Mar 04 05:27 PM
Knightly Kevin C	See Remarks	Feb 28 '24	Option Exercise	87.40	13,206	1,154,211	13,858	Mar 01 05:07 PM
Knightly Kevin C	See Remarks	Feb 28 '24	Sale	250.17	8,607	2,153,176	5,251	Mar 01 05:07 PM
Sherbet Eric	See Remarks	Feb 16 '24	Sale	241.50	1,000	241,500	20,836	Feb 21 05:08 PM
Knightly Kevin C	See Remarks	Feb 16 '24	Option Exercise	78.21	12,149	950,173	18,061	Feb 21 05:07 PM
Knightly Kevin C	See Remarks	Feb 16 '24	Sale	241.10	13,468	3,247,165	652	Feb 21 05:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IQV

IQVIA Holdings Inc

Upgrade your FINVIZ experience